Choice of treatment-effect measures when noninferiority margins originally defined in absolute difference translated into relative difference influenced the results of clinical trials
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 96, 63-72
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority StudiesAnnals of Internal Medicine, 2015
- Choice of effect measure for meta-analyses of dichotomous outcomes influenced the identified heterogeneity and direction of small-study effectsJournal of Clinical Epidemiology, 2015
- Understanding and expressing “Risk”Journal of the Saudi Heart Association, 2010
- The Hazards of Hazard RatiosEpidemiology, 2010
- Different measures of treatment effect for different research questionsJournal of Clinical Epidemiology, 2010
- Measures of effect: Relative risks, odds ratios, risk difference, and ‘number needed to treat’Kidney International, 2007
- Understanding measures of treatment effect in clinical trialsArchives of Disease in Childhood, 2005
- Odds Ratio, Relative Risk, Absolute Risk Reduction, and the Number Needed to Treat—Which of These Should We Use?Value in Health, 2002
- Interpreting Measures of Treatment Effect in Cancer Clinical TrialsThe Oncologist, 2002
- Choice of effect measure for epidemiological dataJournal of Clinical Epidemiology, 2000